Receiving a spinal muscular atrophy (SMA) diagnosis can feel overwhelming and lead to a lot of questions, including, “how do I treat it?” Because SMA is a progressive disease, most people experience a decline in motor function over time. Although the rate and severity can vary among individuals, treatment may help lessen or slow the decline. This makes it important to receive treatment as soon as possible.
Five years ago, SPINRAZA® (nusinersen) made history as the first FDA-approved prescription medicine used to treat SMA in broad range of pediatric and adult patients. SPINRAZA is now approved in over 50 countries. Behind many SMA diagnoses are inspiring stories filled with strength, resilience and perseverance, from people who have been treated with SPINRAZA.
Read more at: https://smanewstoday.com/sponsored-articles/stories-of-sma-the-path-to-treatment/
